カテゴリ： Stratistics MRC, 世界, 医療/バイオ

注意欠如・多動症（ADHD）のグローバル市場（～2027）：覚醒剤、非覚醒剤、その他

■ 英語タイトル：Attention Deficit Hyperactivity Disorder Market Forecasts to 2028 – Global Analysis By medication (Stimulant, Non Stimulant and Other Medications), By Psychotherapy (Behaviour Therapy, Cognitive Behavioural Therapy and Other Psychotherapies), By Education Or Training (Social Skills Training, Parent Management Training and Other Education Or Trainings ), Distribution Channel and By Geography.

調査会社Stratistics MRC社が発行したリサーチレポート（データ管理コード：SMRC23MA036）

■ 発行会社/調査会社：Stratistics MRC
■ 商品コード：SMRC23MA036
■ 発行日：2022年12月
最新版(2025年又は2026年)はお問い合わせください。
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約150
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール

■ 販売価格オプション（消費税別）

Single User		見積依頼/購入/質問フォーム
Global Site License		見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[注意欠如・多動症（ADHD）のグローバル市場（～2027）：覚醒剤、非覚醒剤、その他]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

Stratistics MRC社では、世界の注意欠如・多動症（ADHD）市場規模が2022年に132.1億ドルから2028年には189.5億ドルになり、予測期間中にCAGR 6.2%で成長すると予測しています。本報告書では、注意欠如・多動症（ADHD）の世界市場について幅広く分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、薬物療法別（覚醒剤、非覚醒剤、その他）分析、心理療法別（行動療法、認知行動療法、その他）分析、教育＆訓練別（社会的スキル訓練、親管理訓練、その他）分析、流通チャネル別（小売薬局、病院薬局、専門クリニック、電子商取引）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報など、以下の内容を掲載しています。なお、Noven Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Neos Therapeutics, Inc., Supernus Pharmaceuticals, Novartis AG, Johnson & Johnson, Lilly, Pfizer Inc., Alcobra Ltd.などの企業情報を含んでいます。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の注意欠如・多動症（ADHD）市場規模：薬物療法別
- 覚醒剤の市場規模
- 非覚醒剤の市場規模
- その他薬物の市場規模
・世界の注意欠如・多動症（ADHD）市場規模：心理療法別
- 行動療法の市場規模
- 認知行動療法の市場規模
- その他心理療法の市場規模
・世界の注意欠如・多動症（ADHD）市場規模：教育＆訓練別
- 社会的スキル訓練の市場規模
- 親管理訓練の市場規模
- その他教育＆訓練の市場規模
・世界の注意欠如・多動症（ADHD）市場規模：流通チャネル別
- 小売薬局チャネルの市場規模
- 病院薬局チャネルの市場規模
- 専門クリニックチャネルの市場規模
- 電子商取引チャネルの市場規模
・世界の注意欠如・多動症（ADHD）市場規模：地域別
- 北米の注意欠如・多動症（ADHD）市場規模
- ヨーロッパの注意欠如・多動症（ADHD）市場規模
- アジア太平洋の注意欠如・多動症（ADHD）市場規模
- 南米の注意欠如・多動症（ADHD）市場規模
- 中東・アフリカの注意欠如・多動症（ADHD）市場規模
・最近の動向
・企業情報

Stratistics MRCによると、世界の注意欠如・多動症（ADHD）市場は2022年に132億1,000万ドルを占め、予測期間中の年平均成長率は6.2%で、2028年には189億5,000万ドルに達する見込みです。注意欠如・多動症（ADHD）は、注意困難、多動性、衝動性を含む慢性疾患です。注意欠如・多動症（ADHD）は小児期に発症することが多く、成人期まで続くこともあります。注意欠如・多動症（ADHD）は、自尊心の低下、人間関係のトラブル、学校や職場での困難の原因となることがあります。症状には、注意力の低下や多動性などがあります。多くの治療法がありますが、個々の子供や家族によって、最も効果的な治療法は異なります。

米国疾病予防管理センターによると、2021年9月現在、8.8％の人が人生のある時点で注意欠如・多動症（ADHD）と診断されています。さらに、1,360万人が注意欠如・多動症（ADHD）を主な診断として医師の診察を受けています。また、米国では注意欠如・多動症（ADHD）の治療に対する支出が増加しており、処方率も上昇していることから、市場の拡大が見込まれています。

市場の主要企業

注意欠如・多動症（ADHD）市場の主要企業には、Noven Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Neos Therapeutics, Inc., Supernus Pharmaceuticals, Novartis AG, Johnson & Johnson, Lilly, Pfizer Inc., Alcobra Ltd., Neurosigma, Inc, Hisamitsu Pharmaceutical Co.,Inc , KemPharm, Inc., Curemark, LLC., Mallinckrodt, UCB S.A, Purdue Pharma L.P. Actavisが含まれています。

対象となる薬
– 覚せい剤
– 非刺激剤
– その他の薬物療法

対象となる精神療法
– 行動療法
– 認知行動療法
– 家族療法
– 対人心理療法
– その他の心理療法

教育またはトレーニング
– ソーシャルスキルトレーニング
– 親の管理トレーニング
– 学校ベースの介入
– その他の教育または研修

対象となる流通経路
– 小売薬局
– 病院薬局
– 専門クリニック
– 電子商取引
– その他の流通チャネル

対象地域
– 北米
米国
カナダ
メキシコ
– ヨーロッパ
ドイツ
英国
イタリア
フランス
スペイン
その他のヨーロッパ
– アジア太平洋
日本
中国
インド
オーストラリア
ニュージーランド
韓国
その他のアジア太平洋地域
– 南米
アルゼンチン
ブラジル
チリ
その他の南米諸国
– 中東・アフリカ
サウジアラビア
アラブ首長国連邦
カタール
南アフリカ
その他の中東・アフリカ

*** レポート目次（コンテンツ）***

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Attention Deficit Hyperactivity Disorder Market, By Medication
5.1 Introduction
5.2 Stimulant
5.2.1 Amphetamine
5.2.2 Dexmethylphenidate
5.2.3 Methylphenidate
5.2.4 Methylphenidate
5.2.5 Lisdexamfetamine dimesylate
5.3 Non Stimulant
5.3.1 Atomoxetine
5.3.2 Guanfacine
5.3.3 Atomoxetine
5.3.4 Clonidine
5.4 Other Medications
6 Global Attention Deficit Hyperactivity Disorder Market, By Psychotherapy
6.1 Introduction
6.2 Behaviour Therapy
6.3 Cognitive Behavioural Therapy
6.4 Family Therapy
6.5 Interpersonal Psychotherapy
6.6 Other Psychotherapies
7 Global Attention Deficit Hyperactivity Disorder Market, By Education Or Training
7.1 Introduction
7.2 Social Skills Training
7.3 Parent Management Training
7.4 School-Based Interventions
7.5 Other Education Or Trainings
8 Global Attention Deficit Hyperactivity Disorder Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacy
8.3 Hospital Pharmacy
8.4 Specialty Clinics
8.5 E-Commerce
8.6 Other Distribution Channel
9 Global Attention Deficit Hyperactivity Disorder Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Noven Pharmaceuticals, Inc.
11.2 Takeda Pharmaceutical Company Limited
11.3 Neos Therapeutics, Inc.
11.4 Supernus Pharmaceuticals
11.5 Novartis AG
11.6 Johnson & Johnson
11.7 Lilly, Pfizer Inc.
11.8 Alcobra Ltd.
11.9 Neurosigma, Inc
11.10 Hisamitsu Pharmaceutical Co.,Inc
11.11 KemPharm, Inc.
11.12 Curemark, LLC.
11.13 Mallinckrodt, UCB S.A.
11.14 Purdue Pharma L.P.
11.15 Actavis
List of Tables
Table 1 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 3 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 4 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 5 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 6 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 7 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 8 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 9 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 10 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 11 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 12 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 13 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 14 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 15 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 16 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 17 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 18 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 19 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 20 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 21 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 22 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 23 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 24 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 25 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 26 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 27 Global Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 28 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 29 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 30 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 31 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 32 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 33 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 34 Global Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 35 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 36 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 37 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 38 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 39 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 40 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 41 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 42 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 43 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 44 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 45 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 46 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 47 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 48 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 49 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 50 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 51 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 52 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 53 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 54 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 55 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 56 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 57 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 58 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 59 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 60 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 61 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 62 North America Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 63 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 64 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 65 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 66 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 67 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 68 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 69 North America Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 70 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 71 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 72 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 73 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 74 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 75 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 76 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 77 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 78 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 79 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 80 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 81 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 82 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 83 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 84 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 85 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 86 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 87 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 88 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 89 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 90 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 91 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 92 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 93 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 94 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 95 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 96 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 97 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 98 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 99 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 100 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 101 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 102 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 103 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 104 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 105 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 106 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 107 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 108 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 109 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 110 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 111 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 112 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 113 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 114 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 115 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 116 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 117 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 118 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 119 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 120 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 121 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 122 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 123 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 124 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 125 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 126 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 127 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 128 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 129 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 130 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 131 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 132 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 133 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 134 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 135 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 136 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 137 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 138 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 139 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 140 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 141 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 142 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 143 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 144 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 145 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 146 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 147 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 148 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 149 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 150 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 151 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 152 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 153 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 154 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 155 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 156 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 157 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 158 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 159 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 160 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 161 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 162 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 163 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 164 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 165 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 166 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 167 South America Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 168 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 169 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 170 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 171 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 172 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 173 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 174 South America Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 175 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 176 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 177 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 178 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 179 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 180 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 181 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 182 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 183 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 184 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 185 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 186 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 187 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 188 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 189 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 190 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 191 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 192 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 193 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 194 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 195 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 196 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 197 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 198 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 199 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 200 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 201 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 202 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 203 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 204 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 205 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 206 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 207 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 208 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 209 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 210 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)

※参考情報

注意欠如・多動症（ADHD）は、神経発達障害の一種であり、主に注意力の持続の難しさ、多動性、および衝動性を特徴としています。ADHDは一般的に子供に見られますが、大人でもその症状が持続することがあります。ADHDは社会的、学業的、職業的な障害を引き起こす可能性があるため、早期の診断と適切な支援が重要です。

ADHDは大きく三つのタイプに分類されます。第一のタイプは「注意欠如型」で、これは注意力の持続に関する問題が主な症状です。具体的には、仕事や学業に集中できない、物事を忘れやすい、指示に従うのが難しいなどの特徴があります。

第二のタイプは「多動性・衝動性型」です。このタイプは、過剰な動きや、思いついたことをすぐに行動に移す衝動性を伴います。例えば、座っていることができずに常に動いている、他の人の話を遮ることが多いといった行動が見られます。

第三のタイプは「混合型」で、これは注意欠如型と多動性・衝動性型の両方の症状を持つ場合に該当します。この混合型は最も一般的であり、多くの子供たちがこの分類に該当します。

ADHDの原因はさまざまですが、遺伝的要因が大きいと考えられています。また、環境的要因や脳の構造や機能にも関係があります。具体的には、出生前の母親の健康状態、環境中の有害物質への曝露、早産や低体重出生などがリスクを高める関与があると言われています。

ADHDの治療法には、薬物療法と心理社会的治療の二つが主にあります。薬物療法では、メチルフェニデートやアモキサピンなどの薬剤が用いられ、これにより脳内の神経伝達物質のバランスを改善します。この治療は症状の軽減に効果があるとされています。

心理社会的治療には、行動療法、認知療法、家庭支援プログラムなどが含まれます。行動療法は、望ましい行動を強化し、問題行動を減少させることを目的としています。認知療法は、思考パターンの修正を図り、自己管理能力を高めることに焦点を当てています。

また、ADHDには教育的支援も重要です。特別支援教育や、個別の学習計画を通じて、学習環境を調整し、子供たちの学習効果を高めることが可能です。教師や保護者に対する研修や情報提供も重要な要素です。

最近では、デジタル技術の進化もADHDの支援に寄与しています。アプリやウェアラブルデバイスを使用して、注意力や時間管理をサポートするツールが登場しています。これにより、自己管理スキルを養う手助けができるようになりました。

ADHDに関する理解は年々進展しており、周囲のサポートも重要な役割を果たしています。家族や教育機関がADHDについて正しい知識を持ち、支援を行うことで、ADHDを持つ子供たちの生活の質が向上することが期待されます。ADHDは個々によって症状が異なるため、適切なアプローチを取ることが重要です。

このように、ADHDは複雑な障害であり、個々のニーズに応じた多角的なアプローチが求められます。早期の発見と適切な支援によって、ADHDを持つ人々が自分の強みを活かし、充実した人生を送ることができる可能性が開かれます。各種の専門家や家族、教育者が協力し合うことで、より良い環境を整えられることが望まれます。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

注意欠如・多動症（ADHD）のグローバル市場（～2027）：覚醒剤、非覚醒剤、その他

グローバル市場調査会社